$125 million nationwide settlement in the average wholesale price (AWP) litigation filed in 2002 by consumers and insurance co.

Abbott Laboratories, Amgen Inc., Aventis Pharmaceuticals Inc., Bayer Corporation, Dey, Inc., Pharmacia Corporation, Pharmacia & Upjohn LLC, SICOR, Inc., SICOR Pharmaceuticals, Inc., Watson Pharmaceuticals Inc., CSL Behring LLC, Hoechst Marion Roussel and Baxter Healthcare Corporation agreed to a $125 million nationwide settlement in the average wholesale price (AWP) litigation filed in 2002 by consumers and insurance companies, which claimed the defendants intentionally inflated reports of the average wholesale prices on certain prescription drugs. Drugs covered in this settlement include Aranesp, Epogen, Neupogen, Neulasta, Anzemet, Ferrlecit and Infed.
Biotechnology company Genzyme Corp declared on 6 March the launch of the phosphate binder Renvela (sevelamer carbonate) for dialysis patients in the US plus significant progress in its international efforts to secure additional approvals for the product. More.